University Health Network

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 1999-01-01

Employees: 10K

Market Cap: -

Website: http://www.uhn.ca

Clinical Trials

IV Dexamethasone for Prolongation of Peripheral Nerve Block

Phase 3

Completed

Conditions: Anesthesia, Conduction

Interventions: Drug: IV dexamethasone

First Posted Date: 2016-08-12

Last Posted Date: 2019-03-04

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 18

Registration Number: NCT02864602

Locations: 🇨🇦
Toronto Western Hospital, Toronto, Ontario, Canada

ADT Exercise Trial and Economic Analysis

Phase 3

Completed

Conditions: Prostate Cancer

Interventions: Behavioral: Supervised Group Exercise
Behavioral: Home Based Exercise

First Posted Date: 2016-07-15

Last Posted Date: 2021-04-13

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 38

Registration Number: NCT02834416

Locations: 🇨🇦
University of Calgary/Tom Baker Cancer Centre, Calgary, Alberta, Canada
🇨🇦
Southlake Regional Health Centre, Newmarket, Ontario, Canada
🇨🇦
Scarborough and Rouge Hospital, Toronto, Ontario, Canada

and more 1 locations

Preoperative Brimonidine on IOP of Patients Undergoing RALP

Phase 4

Completed

Conditions: Prostate Cancer

Interventions: Drug: brimonidine tartrate 0.2%
Other: Carboxymethylcellulose Eye Drops

First Posted Date: 2016-06-30

Last Posted Date: 2018-09-27

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 26

Registration Number: NCT02818816

Locations: 🇨🇦
Princess Margaret Cancer Centre, Toronto, Canada

Bone Health in Aging HIV Infected Women

Phase 4

Completed

Conditions: Osteoporosis
HIV
Menopause

Interventions: Drug: tenofovir-alafenamide-emtricitabine
Drug: tenofovir-emtricitabine

First Posted Date: 2016-06-28

Last Posted Date: 2024-12-19

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 34

Registration Number: NCT02815566

Locations: 🇮🇹
Università degli Studi di Modena e Reggio Emilia, Modena, Italy
🇨🇦
Hamilton Health Sciences, Hamilton, Ontario, Canada
🇨🇦
University Health Network, Toronto, Ontario, Canada

and more 4 locations

RCT:Oropharyngeal Leak Pressure (OLP) - Ambu AuraGain vs LMA Supreme

Not Applicable

Completed

Conditions: Laryngeal Masks

Interventions: Device: LMA Supreme
Device: Ambu AuraGain

First Posted Date: 2016-06-28

Last Posted Date: 2017-06-06

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 170

Registration Number: NCT02816463

Locations: 🇨🇦
Toronto Western Hospital, Toronto, Ontario, Canada

The Utility of Circulating Tumour Cells and Plasma microRNA in Esophageal Adenocarcinoma

Completed

Conditions: Esophageal Cancer

Interventions: Other: Blood Draw

First Posted Date: 2016-06-24

Last Posted Date: 2024-03-08

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 84

Registration Number: NCT02812680

Locations: 🇨🇦
University Health Network, Toronto, Ontario, Canada

Diffusion Tensor Breast MRI (DTI)

Not Applicable

Completed

Conditions: Breast Cancer

Interventions: Other: Diffusion tensor imaging (DTI) in Breast MRI

First Posted Date: 2016-06-24

Last Posted Date: 2021-04-13

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 267

Registration Number: NCT02812589

Locations: 🇨🇦
Princess Margaret Cancer Centre, University Health Network, 610 University Ave., Toronto, Ontario, Canada

Study of Azacitidine and Durvalumab in Advanced Solid Tumors

Phase 2

Completed

Conditions: Platinum Resistant Epithelial Ovarian Cancer Type II
Estrogen Receptor Positive and HER2 Negative Breast Cancer
Microsatellite Stable Colorectal Carcinoma

Interventions: Drug: Azacitidine
Drug: Durvalumab

First Posted Date: 2016-06-23

Last Posted Date: 2021-04-01

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 28

Registration Number: NCT02811497

Locations: 🇨🇦
Princess Margaret Cancer Centre, Toronto, Ontario, Canada

In Vivo Lung Perfusion for Pulmonary Metastases of Sarcoma

Phase 1

Recruiting

Conditions: Bone Sarcoma
Soft Tissue Sarcoma
Pulmonary Metastases

Interventions: Drug: Doxorubicin

First Posted Date: 2016-06-23

Last Posted Date: 2024-06-18

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 17

Registration Number: NCT02811523

Locations: 🇨🇦
Princess Margaret Cancer Centre, Toronto, Canada

Assessment of Patient Frailty Prior to Thoracic Surgery

Completed

Conditions: Lung Cancer
Esophageal Cancer

Interventions: Other: Frailty Assessment

First Posted Date: 2016-06-16

Last Posted Date: 2019-05-07

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 40

Registration Number: NCT02803281

Locations: 🇨🇦
University Health Network: Toronto General Hospital, Toronto, Ontario, Canada
🇨🇦
University Health Network, Toronto, Ontario, Canada
🇨🇦
University Health Network (Toronto General Hospital), Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy